HEALEY ALS Platform Trial

Study Purpose:

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

Study Status:

Recruiting

Disease:

Amyotrophic Lateral Sclerosis (ALS) , Familial ALS , Sporadic ALS

Study Type:

Interventional

Type of Intervention:

Drug Trial

Intervention Name:

Zilucoplan, Verdiperstat, CNM-Au8, Pridopidine, SLS-005 Trehalose, ABBV-CLS-7262, and DNL343.

Placebo:

Yes

Phase:

Phase 1/Phase 2

Study Chair(s)/Principal Investigator(s):

Merit Cudkowicz, MD Massachusetts General Hospital

Clinicaltrials.gov ID:

NCT04297683-NEALS

Neals Affiliated?

Yes

Coordinating Center Contact Information

Healey Center for ALS at Massachusetts General Hospital

Platform Trial Research Navigator / email hidden; JavaScript is required / 833-425-8257 (HALT ALS)

Boston, Massachusetts, 02114 United States

Full Study Summary:

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. This trial is designed as a perpetual platform trial. This means that there is a single Master Protocol dictating the conduct of the trial.

In this trial, multiple investigational products for ALS will be tested simultaneously or sequentially. Each investigational product will be tested in a regimen. Each regimen consists of a placebo-controlled trial, meaning that the active investigational product and matching placebo will be tested in each regimen.

The additional details that govern the testing of each investigational product will be summarized in separate regimen-specific appendices (RSAs). Each regimen will have a separate ClinicalTrials.gov posting, which will include specific information about the regimen. All regimen-specific outcome measures will be detailed in each regimen posting.

Participants will have an equal chance to be randomized to all regimens that are active at the time of screening. Once randomized to a regimen, participants will be randomized in a 3:1 ratio to either study drug or placebo.

The following regimens are active in the trial:

Regimen A - Zilucoplan Regimen B - Verdiperstat Regimen C - CNM-Au8 Regimen D - Priodopidine Regimen E - SLS-005 Trehalose Regimen F - ABBV-CLS-7262 - Regimen G - DNL343.

New regimens will be continuously added as new investigational products become available. The HEALEY ALS Platform Trial will enroll additional participants as each new regimen is available.

Study Sponsor:

Merit E. Cudkowicz, MD

Estimated Enrollment:

800

Estimated Study Start Date:

07 / 01 / 2020

Estimated Study Completion Date:

11 / 30 / 2022

Posting Last Modified Date:

11 / 29 / 2022

Date Study Added to neals.org:

03 / 09 / 2020

Visit the Sean M. Healey & AMG Center for ALS at Mass General website for more information: www.massgeneral.org/neurology/als/research/platform-trial

Minimum Age:

Can participants use Riluzole?

Yes

Inclusion Criteria:

Sporadic or familial ALS diagnosed as clinically possible, probable, lab-supported probable, or definite ALS defined by revised El Escorial criteria.
Age 18 years or older.
Capable of providing informed consent and complying with study procedures, in the SI's opinion.
Time since onset of weakness due to ALS ≤ 36 months at the time of the Master Protocol Screening Visit.
SVC ≥ 50% of predicted capacity for age, height, and sex at the time of the Master Protocol Screening Visit.
Participants must either not take riluzole or be on a stable dose of riluzole for ≥ 30 days prior to the Master Protocol Screening Visit. Riluzole-naïve participants are permitted in the study.
Participants must either not take edaravone or have completed at least one cycle of edaravone prior to the Master Protocol Screening Visit. Edaravone-naïve participants are permitted in the study.
Participants must have the ability to swallow pills and liquids at the time of the Master Protocol Screening Visit and, in the SI's opinion, have the ability to swallow for the duration of the study.
Geographically accessible to the site.

Exclusion Criteria:

Clinically significant unstable medical condition (other than ALS) that would pose a risk to the participant, according to SI's judgment (e.g., cardiovascular instability, systemic infection, untreated thyroid dysfunction, or clinically significant laboratory abnormality or EKG changes). Lab abnormalities include, but are not limited to: Hemoglobin < 10 g/dL, White Blood Cells < 3.0 x 103/mm3, Neutrophils, Absolute ≤ 1000/mm3, Eosinophilia (absolute eosinophil count of ≥ 500 eosinophils per microliter), low platelet counts (< 150 x 109 per liter), alanine aminotransferase (ALT) or aspartate aminotransferase (AST) greater than 3 times the upper limit of normal (ULN), eGFR < 30 mL/min/1.73m2, thyroid-stimulating hormone (TSH) levels >10 mIU/L or <0.01 mIU/L.
Presence of unstable psychiatric disease, cognitive impairment, dementia or substance abuse that would impair ability of the participant to provide informed consent, in the SI's opinion.
Active cancer or history of cancer, except for the following: basal cell carcinoma or successfully treated squamous cell carcinoma of the skin, cervical carcinoma in situ, prostatic carcinoma in situ, or other malignancies curatively treated and with no evidence of disease recurrence for at least 3 years.
Use of investigational treatments for ALS (off-label use or active participation in a clinical trial) within 5 half-lives (if known) or 30 days (whichever is longer) prior to the Master Protocol Screening Visit.
Exposure at any time to any gene therapies under investigation for the treatment of ALS (off-label use or investigational).
If female, breastfeeding, known to be pregnant, planning to become pregnant during the study, or of child-bearing potential and unwilling to use effective contraception for the duration of the trial and for 3 months, or longer as specified in each RSA, after discontinuing study treatment.
If male of reproductive capacity, unwilling to use effective contraception for the duration of the trial and for 3 months, or longer as specified in each RSA, after discontinuing study treatment.
Anything that would place the participant at increased risk or preclude the participant's full compliance with or completion of the study, in the SI's opinion.
If a participant is being re-screened, the disqualifying condition has not been resolved, or the mandatory wash-out duration has not occurred.
For those participating in the optional CSF collection, contraindication to undergoing a lumbar puncture (LP) in the SI's opinion. Participants undergoing the LP must not be currently taking anticoagulation medications such as warfarin that would be a contraindication to LP; aspirin and non-steroidal anti-inflammatories are allowed.

Barrow Neurological Institute | Recruiting

Annalee Boyle / email hidden; JavaScript is required

Phoenix, Arizona 85013
United States

Mayo Clinic Scottsdale | Recruiting

Alissa Bojko / 480-301-4902 / email hidden; JavaScript is required

Scottsdale, Arizona
United States

Cedars-Sinai Medical Center | Recruiting

Sophia Mostowy / email hidden; JavaScript is required

Los Angeles, California 90048
United States

University of California, San Francisco | Recruiting

Reshma Kolala / 415-501-0671 / email hidden; JavaScript is required

San Francisco, California
United States

Loma Linda University Health | Recruiting

David Borg / email hidden; JavaScript is required

Loma Linda, California 92354
United States

Kaiser, Los Angeles Medical Center | Recruiting

Mary H. Berganza / email hidden; JavaScript is required

Los Angeles, California 90027
United States

Forbes Norris MDA/ALS Research Center, California Pacific Medical Cente | Recruiting

Daniela Sanchez / 415-600-1734 / email hidden; JavaScript is required

San Francisco, California 94115
United States

University of California, Irvine | Recruiting

Pola Gaid / email hidden; JavaScript is required

Orange, California 92868
United States

University of Southern California | Recruiting

Salma Akhter / 323-442-6221 / email hidden; JavaScript is required

Los Angeles, California 90033
United States

University of Colorado Anschutz | Recruiting

Recruitment Coordinator / email hidden; JavaScript is required

Aurora, Colorado 80045
United States

Hospital for Special Care | Recruiting

Zanib Iqbal / email hidden; JavaScript is required

New Britain, Connecticut 06053
United States

Georgetown University | Recruiting

Eli Wolfgang / email hidden; JavaScript is required

Washington, District of Columbia 20007
United States

George Washington University | Recruiting

Grace Johnson / 202-741-2181 / email hidden; JavaScript is required

Washington, District of Columbia 20037
United States

Nova Southeastern University | Recruiting

Donovan Mott / 954-203-2829 / email hidden; JavaScript is required

Davie, Florida 33314
United States

Phil Smith Neuroscience Institute at Holy Cross Hospital | Active, Non-Recruiting

Ashley Stepler / email hidden; JavaScript is required

Fort Lauderdale, Florida 33308
United States

University of Florida Gainesville | Active, Not recruiting

Jessica Spana / email hidden; JavaScript is required

Gainesville, Florida 32610
United States

Mayo Clinic Florida | Recruiting

Jany Paulett / email hidden; JavaScript is required

Jacksonville, Florida 32224
United States

University of Miami | Active, Not recruiting

Jessica Hernandez / email hidden; JavaScript is required

Miami, Florida 33136
United States

University of South Florida College of Medicine | Recruiting

Jessica Shaw / email hidden; JavaScript is required

Tampa, Florida 33612
United States

Augusta University | Recruiting

Brandy Quarles / 706-721-0390 / email hidden; JavaScript is required

Augusta, Georgia 30912
United States

Saint Alphonsus Regional | Recruiting

Jessica Kemmet / email hidden; JavaScript is required

Boise, Idaho
United States

Northwestern University | Recruiting

Emma Schmidt / email hidden; JavaScript is required

Chicago, Illinois 60611
United States

University of Chicago | Active, Not recruiting

Deekshitha Turaka / 773-702-4392 / email hidden; JavaScript is required

Chicago, Illinois 60637
United States

Indiana University | Recruiting

Sandy Guingrich / 317-963-7382 / email hidden; JavaScript is required

Indianapolis, Indiana 46202
United States

University of Iowa Hospitals and Clinics | Recruiting

Emily Anderson / email hidden; JavaScript is required

Iowa City, Iowa 52242
United States

University of Kansas Medical Center | Active, Not Recruiting

Katheryn Jennens / email hidden; JavaScript is required

Nick Staudenmier / email hidden; JavaScript is required

Fairway, Kansas 66205
United States

University of Kentucky | Recruiting

Sura Al Hilfi / 859-218-5064 / email hidden; JavaScript is required

Lexington, Kentucky 40536
United States

Ochsner Health System | Active, Not recruiting

Lisa Edmond / 985-989-7182 / email hidden; JavaScript is required

New Orleans, Louisiana 70115
United States

Johns Hopkins University | Recruiting

Kristen Riley / email hidden; JavaScript is required

Baltimore, Maryland 21205
United States

University of Maryland | Recruiting

Vikram Nambiar / email hidden; JavaScript is required

Baltimore, Maryland 21201
United States

Beth Israel Deaconess Medical Center | Recruiting

Teresa Capella / email hidden; JavaScript is required

Boston, Massachusetts 02215
United States

Massachusetts General Hospital | Recruiting

Ludjie Jean Pierre / 617-643-3902 / email hidden; JavaScript is required

Boston, Massachusetts 02114
United States

University of Massachusetts Medical School | Recruiting

Catherine Douthwright / email hidden; JavaScript is required

North Worcester, Massachusetts 01655
United States

University of Michigan | Recruiting

Jayna Duell / email hidden; JavaScript is required

Ann Arbor, Michigan 48109
United States

Henry Ford Health System | Recruiting

Beverley Duthie / email hidden; JavaScript is required

Detroit, Michigan 48202
United States

Spectrum Health | Recruiting

Sehrish Khan / email hidden; JavaScript is required

Grand Rapids, Michigan 49525
United States

Mayo Clinic Rochester | Recruiting

Brenda Nelson / 507-293-0545 / email hidden; JavaScript is required

Rochester, Minnesota 55902
United States

University of Minnesota/Twin Cities ALS Research Consortium | Recruiting

Valerie Ferment / email hidden; JavaScript is required

Minneapolis, Minnesota 55455
United States

Essentia Health | Recruiting

Brent Gavin / 218-786-1220 / email hidden; JavaScript is required

Duluth, Minnesota
United States

Saint Louis University | Active, Not recruiting

Elizabeth (Bitsy) Egan / 314-977-4900 / email hidden; JavaScript is required

Saint Louis, Missouri 63104
United States

University of Missouri Health Care | Active, Not recruiting

N/A / N/A

Columbia, Missouri 65212
United States

Washington University School of Medicine | Recruiting

Rebecca Livigni / email hidden; JavaScript is required

Saint Louis, Missouri 63110
United States

University of Nebraska Medical Center | Recruiting

Rachel Harper / 402-552-6233 / email hidden; JavaScript is required

Omaha, Nebraska 68198
United States

Neurology Associates, P.C./Somnos Clinical Research | Active, Not recruiting

Desirae Eschiti / email hidden; JavaScript is required

Lincoln, Nebraska 68506
United States

Las Vegas Clinic | Active, Not-Recruiting

Kevin Daniels / 702-505-4230 / email hidden; JavaScript is required

Las Vegas, Nevada 89145
United States

Dartmouth-Hitchcock Medical Center | Active, Not recruiting

Gina Kersey / email hidden; JavaScript is required

Lebanon, New Hampshire 03756
United States

Hackensack University Medical Center | Recruiting

Rebecca Philip / email hidden; JavaScript is required

Michelle Williams / email hidden; JavaScript is required

Hackensack, New Jersey 07601
United States

Columbia University | Recruiting

Oneika Blackman / email hidden; JavaScript is required

New York, New York 10032
United States

SUNY Upstate | Recruiting

Lena Deb / email hidden; JavaScript is required

Syracuse, New York 13202
United States

Stony Brook University | Recruiting

Christiana Pol / email hidden; JavaScript is required

Stony Brook, New York
United States

Duke University | Recruiting

Michelle Ward / email hidden; JavaScript is required

Durham, North Carolina 27702
United States

Wake Forest Health Science | Recruiting

Mozhdeh Marandi / email hidden; JavaScript is required

Winston-Salem, North Carolina 27157
United States

University of Cincinnati | Recruiting

Ashley Smith / email hidden; JavaScript is required

Cincinnati, Ohio
United States

The Ohio State University | Recruiting

Elizabeth Wiley / email hidden; JavaScript is required

Columbus, Ohio 43221
United States

Cleveland Clinic | Recruiting

Irys Caristo / 216-444-0173 / email hidden; JavaScript is required

Cleaveland, Ohio 44195
United States

Providence Brain and Spine Institute ALS Center | Recruiting

Ashley Adamo / email hidden; JavaScript is required

Portland, Oregon 97213
United States

University of Pennsylvania | Recruiting

Matthew Burst / email hidden; JavaScript is required

Philadelphia, Pennsylvania 19107
United States

Thomas Jefferson University, Jefferson Weinberg ALS Center | Recruiting

Amir Ahmadi / 267-357-1150 / email hidden; JavaScript is required

Philadelphia, Pennsylvania 19107
United States

University of Pittsburgh Medical Center | Recruiting

Research Coordinator / 412-864-2873 / email hidden; JavaScript is required

Pittsburgh, Pennsylvania 15232
United States

Temple University, Lewis Katz School of Medicine | Active, Not recruiting

Kathleen Hatala / email hidden; JavaScript is required

Philadelphia, Pennsylvania 19140
United States

Penn State Hershey | Recruiting

Michele Hare / email hidden; JavaScript is required

Hershey, Pennsylvania 17033
United States

Lehigh Valley Health Network | Recruiting

Andrew Orzel / 610-402-9543 / email hidden; JavaScript is required

Allentown, Pennsylvania 18103
United States

Vanderbilt University Medical Center | Recruiting

Diana Davis / email hidden; JavaScript is required

Nashville, Tennessee 37232
United States

Texas Neurology | Recruiting

Mohamad Asaad Nasri / email hidden; JavaScript is required

Dallas, Texas 75214
United States

Houston Methodist | Recruiting

Aramide Balogun / 346-238-8226 / email hidden; JavaScript is required

Houston, Texas 77030
United States

University of Texas Health Science Center at San Antonio (UTHSCSA) | Active, Not recruiting

Randee Kent-Baron / 210-450-0524 / email hidden; JavaScript is required

San Antonio, Texas 78229
United States

University of Utah | Recruiting

Crystal Neate / email hidden; JavaScript is required

Salt Lake City, Utah 84132
United States

University of Virginia | Active, Not recruiting

Mary Wagoner / email hidden; JavaScript is required

Charlottesville, Virginia 22908
United States

Virginia Commonwealth University | Recruiting

Demetrius Carter / email hidden; JavaScript is required

Henrico, Virginia
United States

Swedish Medical Center | Recruiting

Will Rowles / 206-320-2609 / email hidden; JavaScript is required

Seattle, Washington
United States

University of Washington | Recruiting

Kassie Chu / email hidden; JavaScript is required

Seattle, Washington 98195
United States

Medical College of Wisconsin | Recruiting

Marie Mejaki / email hidden; JavaScript is required

Milwaukee, Wisconsin 53226
United States

Yale University | Active, Recruiting

Erika Renkl / 475-254-9169 / email hidden; JavaScript is required

New Haven, Conneticut

Atrium Health (North Carolina) | Active, Recruiting

Cynthia Lary / 704-355-9434 / email hidden; JavaScript is required

Charlotte, North Carolina

University of North Carolina (North Carolina) | Active, Recruiting

Said Alhassan / 919-966-0515 / email hidden; JavaScript is required